Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Irvine, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Eledon Pharmaceuticals, Inc. has filed 608 SEC EDGAR filings since 18 Jun 2007

SEC filing history

Showing 451-475 of 605 matching filings.

Per page
25
Current page
19
UPLOAD

UPLOAD filing

Filing date
31 Mar 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRER14A File 001-36620

AMENDMENT NO 2 PRER14A

Filing date
24 Mar 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
23 Mar 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36620

FORM 8-K

Filing date
09 Mar 2017
Reporting date
08 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
PRER14A File 001-36620

PRER14A

Filing date
09 Mar 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
IRANNOTICE File 001-36620

IRANNOTICE

Filing date
03 Mar 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-216432

S-8

Filing date
03 Mar 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
23 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88334

AMENDMENT NO.2 TO FORM SC 13G

Filing date
13 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36620

FORM 8-K

Filing date
03 Feb 2017
Reporting date
31 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-36620

FORM 8-K

Filing date
03 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PREM14A File 001-36620

PREM14A

Filing date
24 Jan 2017
Reporting date
23 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-88334

SC 13D

Filing date
05 Jan 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36620

8-K

Filing date
22 Dec 2016
Reporting date
21 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-36620

8-K

Filing date
22 Dec 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36620

FORM 8-K

Filing date
12 Oct 2016
Reporting date
10 Oct 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36620

FORM 8-K

Filing date
22 Aug 2016
Reporting date
22 Aug 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36620

FORM 8-K

Filing date
03 Aug 2016
Reporting date
28 Jul 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36620

FORM 8-K

Filing date
26 Jul 2016
Reporting date
26 Jul 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
16 Jun 2016
Reporting date
15 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
16 Jun 2016
Reporting date
16 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
16 Jun 2016
Reporting date
15 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .